Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

NCT00004842 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

NIH

Sponsor class

Conditions

Cholangitis, Sclerosing
Liver Cirrhosis, Biliary

Interventions

DRUG: budesonide

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborators

[object Object]